<HashMap><database>biostudies-literature</database><scores/><additional><submitter>White LK</submitter><funding>NIMH NIH HHS</funding><funding>National Institute of Mental Health</funding><pagination>313-322</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9725107</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>66(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The world has suffered immeasurably during the COVID-19 pandemic. Increased distress and mental and medical health concerns are collateral consequences to the disease itself. The Genes to Mental Health (G2MH) Network consortium sought to understand how individuals affected by the rare copy number variations of 22q11.2 deletion and duplication syndrome, associated with neurodevelopmental/neuropsychiatric conditions, were coping. The article focuses on worry and disruptions in medical care caused by the pandemic.&lt;h4>Methods&lt;/h4>The University of Pennsylvania COVID-19 Stressor List and care disruption questions were circulated by 22 advocacy groups in English and 11 other languages.&lt;h4>Results&lt;/h4>A total of 512 people from 23 countries completed the survey; most were careg</pubmed_abstract><journal>Journal of intellectual disability research : JIDR</journal><pubmed_title>The COVID-19 pandemic's impact on worry and medical disruptions reported by individuals with chromosome 22q11.2 copy number variants and their caregivers.</pubmed_title><pmcid>PMC9725107</pmcid><funding_grant_id>U01 MH119705</funding_grant_id><funding_grant_id>1U01MH119738</funding_grant_id><pubmed_authors>Gur RE</pubmed_authors><pubmed_authors>Donald KA</pubmed_authors><pubmed_authors>Maillard AM</pubmed_authors><pubmed_authors>Crowley TB</pubmed_authors><pubmed_authors>Garcia-Minaur S</pubmed_authors><pubmed_authors>Bassett AS</pubmed_authors><pubmed_authors>van den Bree M</pubmed_authors><pubmed_authors>Fischer M</pubmed_authors><pubmed_authors>McDonald-McGinn DM</pubmed_authors><pubmed_authors>Repetto GM</pubmed_authors><pubmed_authors>Swillen A</pubmed_authors><pubmed_authors>White LK</pubmed_authors><pubmed_authors>Finucane B</pubmed_authors><pubmed_authors>Jacquemont S</pubmed_authors><pubmed_authors>Barzilay R</pubmed_authors></additional><is_claimable>false</is_claimable><name>The COVID-19 pandemic's impact on worry and medical disruptions reported by individuals with chromosome 22q11.2 copy number variants and their caregivers.</name><description>&lt;h4>Background&lt;/h4>The world has suffered immeasurably during the COVID-19 pandemic. Increased distress and mental and medical health concerns are collateral consequences to the disease itself. The Genes to Mental Health (G2MH) Network consortium sought to understand how individuals affected by the rare copy number variations of 22q11.2 deletion and duplication syndrome, associated with neurodevelopmental/neuropsychiatric conditions, were coping. The article focuses on worry and disruptions in medical care caused by the pandemic.&lt;h4>Methods&lt;/h4>The University of Pennsylvania COVID-19 Stressor List and care disruption questions were circulated by 22 advocacy groups in English and 11 other languages.&lt;h4>Results&lt;/h4>A total of 512 people from 23 countries completed the survey; most were careg</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-19T05:57:42.397Z</modification><creation>2025-04-19T05:57:42.397Z</creation></dates><accession>S-EPMC9725107</accession><cross_references><pubmed>35191118</pubmed><doi>10.1111/jir.12918</doi></cross_references></HashMap>